This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Influenza A H3N2 Matrix Protein 2 Ectodomain (M2e), N-GST and C-His
Product Overview
BioVenic's Recombinant Influenza A H3N2 Matrix Protein 2 Ectodomain (M2e), N-GST and C-His is a recombinant protein expressed from E.coli Expression System. Its predicted molecular weight is 31.0 kDa. The purity is>90% (SDS-PAGE).
Specifications
Target Information
M2e is the highly conserved 23-amino acid N-terminal extracellular domain of the M2 ion channel in Influenza A (H3N2). While the viral surface glycoproteins HA and NA undergo frequent antigenic drift, the M2e sequence remains remarkably stable across seasonal H3N2 strains. In the H3N2 subtype, M2e serves as a critical target for "universal" vaccine strategies. Antibodies directed against H3N2 M2e facilitate the clearance of infected host cells through Fc-mediated effector functions, such as antibody-dependent cellular cytotoxicity (ADCC) and phagocytosis, providing broad heterosubtypic protection.
Shipping and Storage
This product is shipped with gel ice bags. Avoid repeated freezing and thawing. Store for 12 months at -20°C or -80°C.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.